Category: <span>VS-6063</span>

Category: VS-6063

alimta, COMMAND, Data Safety Monitoring Board, Defactinib, focal adhesion kinase, Joseph Pantgins, Lou Vaickus, malignant pleural mesothelioma, mesothelioma clinical trials, Mesothelioma News, Robert Forrester, Verastem, VS-4718, VS-5584, VS-6063

Verastem Mesothelioma Clinical Trial Stopped Early For Futility

 

The Boston-based company Verastem has stopped its mesothelioma clinical trial early due to futile results in the Phase 2 study of VS-6063.

asbestos, cancer, Cape Town, conference, FAK, focal adhesion kinase, iMig, Inc., inhibitor, International Mesothelioma Interest Group, merlin, Mesothelioma News, South Africa, stem cell, target, tumor suppressor, Verastem, VS-6063

Research Team to Give Exciting Presentations at Mesothelioma Conference in South Africa

 

Drug Developer to Present New Data at Annual Mesothelioma Conference